NEW YORK, March 22 (GenomeWeb News) - Molecular Devices plans to acquire Axon Instruments for a total of $140 million in cash and stock, the company said yesterday.


Molecular Devices, based in Sunnyvale, Calif., hopes the acquisition will create synergies for product development and will help distribute Axon's products more effectively.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.